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Gene expression analysis of Atlantic 
salmon gills reveals mucin 5 and 
interleukin 4/13 as key molecules 
during amoebic gill disease
Mar Marcos-López1,2, Josep A. Calduch-Giner3, Luca Mirimin1, Eugene MacCarthy1, 
Hamish D. Rodger2, Ian O’Connor1, Ariadna Sitjà-Bobadilla4, Jaume Pérez-Sánchez3 & 
M. Carla Piazzon  4
Amoebic gill disease (AGD) is one of the main diseases affecting Atlantic salmon (Salmo salar L.) 
mariculture. Hallmarks of AGD are hyperplasia of the lamellar epithelium and increased production 
of gill mucus. This study investigated the expression of genes involved in mucus secretion, cell cycle 
regulation, immunity and oxidative stress in gills using a targeted 21-gene PCR array. Gill samples 
were obtained from experimental and natural Neoparamoeba perurans infections, and sampling points 
included progressive infection stages and post-freshwater treatment. Up-regulation of genes related 
to mucin secretion and cell proliferation, and down-regulation of pro-inflammatory and pro-apoptotic 
genes were associated with AGD severity, while partial restoration of the gill homeostasis was detected 
post-treatment. Mucins and Th2 cytokines accoun ted for most of the variability observed between 
groups highlighting their key role in AGD. Two mucins (muc5, muc18) showed differential regulation upon 
disease. Substantial up-regulation of the secreted muc5 was detected in clinical AGD, and the membrane 
bound muc18 showed an opposite pattern. Th2 cytokines, il4/13a and il4/13b2, were significantly up-
regulated from 2 days post-infection onwards, and changes were lesion-specific. Despite the differences 
between experimental and natural infections, both yielded comparable results that underline the 
importance of the studied genes in the respiratory organs of fish, and during AGD progression.
Gill diseases, caused by infectious and non-infectious agents, are one of the main health challenges for marine 
Atlantic salmon (Salmo salar L.) aquaculture worldwide1–5. Amoebic gill disease (AGD), caused by the marine 
parasite Neoparamoeba perurans, is present in all salmon producing countries, and its impact has increased dras-
tically in recent years due to the expansion of its geographic distribution and host range4,6,7. Fish suffering from 
AGD display a marked hyperplasia and fusion of the lamellar epithelium, increased number of goblet cells, and 
increased production of gill mucus. Lesions are visible macroscopically as white raised mucoid patches in the 
gill filaments8,9. At present, no preventive measures exist, and freshwater or hydrogen peroxide baths are the 
only available treatments. The success of freshwater treatment is attributed to the osmotic shock on amoebae, 
together with hydration and subsequent reduction of gill mucus viscosity. Decreased mucus viscosity facilitates 
the removal of amoebae and excess mucus with the water flow10,11. Epithelial proliferation and increased mucus 
secretion are common hallmarks of many gill diseases, but the molecular mechanisms underlying these patho-
logical changes are not well understood. Characterization of the proliferative host response is important since it 
ultimately leads to respiratory distress in affected fish, and can result in mortalities if left untreated.
Mucus covering epithelial surfaces is composed of mucins and a complex mixture of proteins, enzymes, ions 
and lipids12. Mucins, the most abundant components of mucus, are high molecular weight glycoproteins secreted 
by goblet cells and described to play important roles in innate immunity, accommodation of the commensal flora, 
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and limitation of pathogens13. Mucins are classified into secreted (mostly gel-forming) or membrane-bound, 
and to date more than 20 mucin genes have been identified in higher vertebrates. In humans, mucins have been 
extensively studied and are used as biomarkers for several diseases, including cancer and airway disorders14,15. 
The wealth of data available from mammals contrasts with the limited data existing for fish mucins. The large 
size and repetitive sequence of mucins peptidic chains complicate their characterization. Nonetheless, the recent 
availability of extensive sequence databases can be a useful resource to identify and study these molecules, par-
ticularly in lower vertebrates where information is scarce. Mucin genes in fish have been described for a small 
number of teleost species including zebrafish (Danio rerio)16,17, gilthead sea bream (Sparus aurata)18, common 
carp (Cyprinus carpio)19, and sea trout (Salmo trutta)20. In Atlantic salmon, many mucin sequences can be found 
as predicted sequences in the databases based on homology with other species, but only recently, gene expression 
analyses have been carried out to detect expression of mucins in mucosal tissues of this species21. Prior to this, 
there was only one report identifying mucin gene expression in skin of Atlantic salmon22.
Previous studies on AGD gene expression have largely focused on immune genes23–27 or microarray-based 
transcriptome profiling28–30. Based on this information, the present study was designed as a targeted approach 
pinpointing genes of interest belonging to pathways involved in mucus secretion, cell proliferation and apoptosis, 
and oxidative/cellular stress during an experimentally controlled AGD infection and a natural outbreak. Immune 
markers known to be differentially expressed in AGD23 (tnfα3, il4/13a, il4/13b2 and tgfβ1b), but also related to 
mucin secretion or cell hyperplasia, were as well included. The rationale for the selection of genes was also sup-
ported by previous proteomic31 studies, and known gene functions in other animal species; such as stimulation of 
mucin secretion (MUC5AC/MUC5B) by Th2 interleukins32,33 and epidermal growth factor receptor (EGFR)34,35 
in mammals, or the important role of mitogen activated protein kinase (MAPK) pathways and Krüppel-like fac-
tors (KLFs) in cell cycle regulation36,37. Sequential gill samples comprising progressive infection and disease stages 
were obtained from an in vivo N. perurans bath challenge and from a natural infection in a commercial Atlantic 
salmon farm. For the field trial, samples were also collected post-freshwater treatment and gill samples were fur-
ther divided into lesion and non-lesion areas. The results obtained contribute to the ongoing understanding of 
AGD host response and pathogenesis and identify key molecules involved in gill health.
Results
In vivo challenge. An experimental in vivo challenge was performed to assess the gill response upon infec-
tion under controlled conditions. The details of the in vivo challenge are summarized in Fig. 1. Cultured N. 
perurans collected from naturally infected fish (Fig. 2A) were used to infect by bath challenge naïve Atlantic 
salmon smolts. Gill scoring (Fig. 2B) and lethal samples were taken after 2, 7, 14 and 21 days post-infection 
(dpi). Macroscopically, challenged fish did not show gross AGD lesions at 2 and 7 dpi (overall gill score (GS) 
of 0), and showed average gill scores (SEM) of 1.9 (0.18) and 3.3 (0.21) at 14 and 21 dpi, respectively (Fig. 2B). 
Histopathological assessment of infected samples revealed mild foci of epithelial hyperplasia at 2 dpi, and 
Figure 1. Schematic representation of the two different trials (in vivo challenge with Neoparamoeba perurans 
and field sampling) used in this study. SD = initial stocking density. Black dots represent the sequential sampling 
points (dpi = days post-infection; dpt = days post-transfer). Blue arrows in the field sampling section show 
initial sea transfer and posterior freshwater treatment. Details on type of lethal samples taken are described in 
the material and methods section.
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microscopic lesions consistent with AGD (i.e. multifocal hyperplasia and fusion of the lamellar epithelium and 
presence of amoebae in close association with lesion areas) from 7 dpi onwards (Fig. 3). N. perurans was detected 
by real-time PCR in 50% of the fish sampled at 2 dpi, and in 100% of the fish sampled at 7, 14 and 21 dpi. Samples 
from non-infected tanks subjected to gill scores, real-time PCR and histopathology analysis, remained negative 
for the duration of the experiment.
Field sampling. To determine the response upon natural infection, field samples were obtained from a com-
mercial farm suffering an AGD outbreak. Fish were monitored and sampled from sea transfer to the development 
of disease signs and subsequent freshwater treatment (Fig. 1). No macro- or microscopic AGD lesions were noted 
in any of the fish sampled at 21 days post-transfer (dpt) (GS 0), and all fish sampled at GS 0 tested negative for N. 
perurans by PCR. At 85 dpt (GS 1) and 92 dpt (GS 2), all fish obtained for analysis displayed gross AGD lesions 
consistent with stage 1 or 2 of disease severity, respectively. The average pen gill score (SEM) at the day of sam-
pling was 0.5 (0.09) for GS 1 and 1.7 (0.11) for GS 2. AGD was confirmed by histopathology (Fig. 3C) and all fish 
sampled at GS 1 and GS 2 tested positive for N. perurans by PCR. At the sampling point carried out four days after 
freshwater treatment (112 dpt), AGD lesions were still visible macroscopically but these appeared to have less 
depth, less mucus and were paler in colour. Histopathology demonstrated multifocal proliferation of the lamellar 
epithelium, but hyperplastic foci were composed of fewer lamellae and regression of the inter-lamellar cell mass 
was apparent in most lesions (Fig. 3D). No amoebae were observed in the histology sections, but two out of the 
five fish sampled were positive by PCR. No other significant gill pathology was noted by gross or histopathological 
examination at any of the sampling points.
Gene sequence analysis. This study aimed to determine the specific expression dynamics of several tar-
geted genes in Atlantic salmon gills during AGD. To that aim, a 21 gene PCR array was specifically designed to 
measure the expression of mucins, mitogen-activated protein kinases, Krüppel-like factors, cytokines, markers 
of oxidative stress, cell proliferation, apoptosis and inflammation, and proteins previously detected to be dif-
ferentially expressed in AGD in a proteomic study31 (Table 1). BLAST searches in the Atlantic salmon genome 
using mucin sequences described for other fish species resulted in the identification of four significant matches 
Figure 2. (A) Cultured Neoparamoeba perurans in marine malt yeast agar plates covered with filtered and 
sterile seawater (x400). (B) Macroscopic AGD lesions in experimentally infected fish sampled at 21 dpi. Note 
mucoid patches at base of filaments (yellow circles).
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of predicted mucin sequences in Atlantic salmon when using gilthead sea bream mucins. Detected mucins were 
muc18 (E-value 1e−85) also known as melanoma cell adhesion molecule, muc2 (E-value 0) annotated in GenBank 
as intestinal mucin-like, muc2-like (E-value 0) and muc19 (E-value 4e−75). Several primers were designed and 
a preliminary optimization study showed that only muc18 and muc2, together with muc5 previously detected 
in Atlantic salmon skin22, were expressed in Atlantic salmon gills (data not shown). The phylogenetic tree con-
structed for Atlantic salmon mucins evidenced the correct classification and grouping of Atlantic salmon mucins 
with the same type mucins as other teleost and animal species (Fig. 4).
The mitogen-activated protein kinases (MAPK) family includes extracellular signal-regulated kinases (ERK), 
p38 and c-Jun N-terminal kinases. Sequences previously described in Atlantic salmon were identified for erk1 
(mapk3), p38a, p38b1 and p38b2. Predicted Atlantic salmon sequences for erk2 (mapk1), erk3 (mapk6) and 
jnk1 (mapk8) were detected from BLAST searches using characterised sequences from zebrafish. Primers were 
designed for all seven mapk genes, but based on Ct values and analysis of melting curves in a preliminary PCR 
analysis (data not shown), only p38b (primers designed to detect both p38b1 and p38b2), erk3 and jnk1 were 
consistently expressed in gills and thus selected for gene expression analysis. Atlantic salmon sequences were 
unequivocally found for all other genes used in this study and their expression in gills was also confirmed by a 
preliminary PCR analysis.
Gene expression profile. Global assessment: Principal component analysis. To obtain an overview of the 
expression profiles of the different groups tested we performed exploratory data analyses using principal compo-
nent analysis (PCA). The PCA analysis of the expression profile of the 21 selected genes in gills for the challenge 
samples (Fig. 5) showed that samples taken at the early stages of infection (2 and 7 dpi) were very similar and with 
low variability. Consecutive samples (14 and 21 dpi) displayed an increasing deviation along the principal compo-
nent 1 (PC1) that contributed to most (98.4%) of the observed variation. Samples taken at 14 and 21 dpi formed 
clearly distinct clusters, and variability among individual samples within groups increased with disease severity.
The PCA analysis for the field samples, performed with fold-changes for lesion areas at GS 1, GS 2, and treated 
groups, relative to GS 0 (Fig. 6A), showed a shift along PC1 that correlated with the disease severity. Upon treat-
ment, a reversion to control values could be observed on PC1. Similar to the results obtained for the in vivo 
challenge, variability among individual samples within groups again increased with disease severity. PC1 and 
PC2 contributed to 51.4% and 25.2% of the observed variability, respectively. An additional PCA analysis was 
performed using fold-changes of all samples (lesion and non-lesion areas of all sampling points) in relation to GS 
0 (Fig. 6B). This analysis revealed that non-lesion areas of GS 1 and GS 2 and treated groups were very close to GS 
0 along the PC1 (45.9% of the observed variability) and separated from lesion areas on both PC1 and PC2 (24.7% 
of the observed variability). Interestingly, lesion-treated samples were very close to the non-lesion GS 1 and GS 2 
groups, while non-lesion treated samples were closer to GS 0.
When exploring into more detail the factors that contributed most to PC1 and PC2 in the PCA analyses 
of Figs 5 and 6, it was determined that most of the variability was driven by the expression of mucins, il4/13a, 
Figure 3. Histopathology assessment of AGD infection (H&E staining). (A) Sample from negative control 
fish at 2 dpi showing non-infected gills with normal lamellar structure. Scale bar = 300 μm. (B) Sample from 
infected fish at 2 dpi showing infection signs such as mild focal hyperplasia and fusion of lamellar epithelium 
(*). Scale bar = 200 μm. (C) Sample from GS 2 fish (field sampling) showing moderate multifocal hyperplasia 
and fusion of lamellar epithelium (*) with associated presence of amoeboid organisms (arrow heads). Scale 
bar = 200 μm. (D) Histology sample taken 4 days after freshwater treatment with less prominent hyperplastic 
foci. Note regression of inter-lamellar cell mass (arrows). Scale bar = 200 μm.
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il4/13b2 and tnfα3. The contribution values for all the genes studied can be found in Supplementary Table S1. In 
order to assess whether changes in these genes were related to disease severity, partial least squares regression 
(PLSR) was performed using the matrix of expression values of mucins, il4/13a, il4/13b2 and tnfα3 as the X vari-
able, and the gill score as Y variable. The results from the controlled in vivo challenge experiment were used as the 
training set to construct the model to predict the gill scores of the field experiment. The results of the prediction 
are shown in Table 2 and clearly show a correlation of the expression of these genes with the severity of the infec-
tion (i.e. GS) in lesion areas. On the other hand, as already seen in the PCA analyses, the model predicts gill scores 
closer to the control value (GS 0) for the non-lesion and treated groups.
Detailed assessment: Gene expression analysis. The results of the exploratory data analyses clearly showed that 
changes related to disease severity were taking place and that freshwater treatment was able to revert, at least par-
tially, to the control phenotype. Therefore, we proceeded to study these changes in detail in order to further char-
acterize the mechanisms involved in AGD progression. The relative mRNA expression of the 21 studied genes for 
all individual samples are shown in Supplementary Table S2 (in vivo challenge) and Supplementary Table S3 (field 
samples). From the 21 genes analysed, 17 genes in the in vivo challenge and 14 genes in the field sampling showed 
statistically significant different expression in at least one of the sampling points. Of note, some genes were so 
consistently expressed that they showed statistical significance differences despite showing low fold change values 
(i.e. jnk1 or nrf2). To simplify the visualization of the results, only fold changes (FC) of the differentially regulated 
genes are represented in Fig. 7 (in vivo challenge) and Fig. 8 (field samples).
In both trials, mucins (especially muc5) and cytokines (particularly il4/13a and il4/13b2) showed the most 
substantial and consistent changes between infected and non-infected or treated samples, and between lesion and 
non-lesion areas. muc5 was progressively and substantially up-regulated at 14 (FC = 7.94) and 21 (FC = 28.61) 
dpi, and in lesion areas at GS 1 (FC = 6.20) and GS 2 (FC = 7.57), whereas muc18 was down-regulated at 21 
dpi. Both mucins showed a reversed trend post-treatment, with down-regulation of muc5 and up-regulation 
of muc18 in treated lesions versus GS 2 lesions. For the immune genes, il4/13a and il4/13b2 were significantly 
up-regulated in infected fish at all sampling points and in lesion areas of GS 1 and GS 2 (except for il4/13b2 at GS 
1), whereas tnfα3 showed a progressive down-regulation from 7 to 21 dpi and tgfß1b was down-regulated at 21 
dpi. As observed for the mucin genes, reversed and significant fold changes were detected for all cytokines tested 
after treatment. muc2 was detected in gills, but the expression was very low and variable between individuals. No 
significant differences were detected in relation to disease progression, but interestingly, muc2 expression in the in 
vivo challenge samples was detected in all individuals except in three out of the six individuals from the infected 
group at 21 dpi (Supplementary Table S2).
Pathway Gene name (Symbol) Accession number Sequence (5′-3′)
Housekeeping ß-actin (ß-act) AF012125 (F):CCATCCAGGCAGTGTTGT; (R):CGGAGTCCATGACGATACC
Mucins
mucin 18 (muc18) XM_014213637 (F):AAGAGCAGCGAGGTGGTG; (R):TCCGTTGACTTGGCAGATGA
mucin 5 (muc5) JT819124 (F):CCGTGCTGGGAGACATTATGAAGT; (R):TGCTGGAGAGGGAAAGGGTAAC
mucin 2 (muc2) XM_014183074 (F):CGACTGCCACAAAGCCATTAGG; (R):GCGTGTTGCTGCGTGTCTT
Immune genes
tumor necrosis factor α3 (tnfα3) NM_001123617 (F):GTGTATGTGGGAGCAGTGTT; (R):GAAGCCTGTTCTCTGTGACT
interleukin 4/13a (il4/13a) AB574339 (F):GCATCGTTGTGAAGAGCCAAGA; (R):GAAGTCTCCTCAGCTCCACCT
interleukin 4/13b2 (il4/13b2) HG794525 (F):GTGAAGGAGAACGGTGATGAGGAACAGC; (R):GGCACAGTTGAAGAGGTTTGTCAGGAGAT
transforming growth factor β 1b (tgfß1b) XM_014129261 (F):GCCATCCGTGGACAGATACT; (R):TCTCCCTCCTGGTCAATCTCT
MAPK pathways
mitogen-activated protein kinase p38b (p38b) EF123660, EF123661 (F):ACGGGTCTGAAGATCGCTGTGAA; (R):TCTGTAGGTTCTCTTGGCGTGGAT
extracellular signal–regulated kinase 3 (erk3) XM_014176343 (F):CACAGCACTCTGGACACT; (R):ACCTCCTCCTCGTCAGTT
c-Jun N-terminal protein kinase 1 (jnk1) XM_014158394 (F):GCGGCTGTCCTATCTGCTCTAC; (R):CGGCGTGAAGGTGCTTGATG
Oxidative and cellular 
stress
nuclear factor erythroid 2-related factor 2 (nrf2) NM_001139807 (F):GAGGGACGAGGATGGGAAG; (R):ATCGGTGGTCTGCTGGAG
heat shock 70 kDa protein (hsp70) NM_001141684 (F):CCTGCCTACTTCAACGATTCACAGAGACA; (R):CCAGCGATCACTCCAGCGTCCTTA
Cell proliferation
Prohibitin (phb) NM_001140130 (F):GGAGAGGACTACGACGAGAGG; (R):CCACCACGGACTTGAGGAC
peptidylprolyl isomerase A (ppia) NM_001146606 (F):CTGCTAACACCGACTGGCTGAAC; (R):CTCCACGACCTTGCCGAACAC
proliferating cell nuclear antigen (pcna) BT056931 (F):GCCGTGACCTGTCTCAGATTG, (R):CCGAGAACTTAACGCCATCCTT
epidermal growth factor receptor (egfr) XM_014191766 (F):GACACCAAGTTCTACCAGAGCCTAATCAGT; (R):GCGTCCACAGCGTCCTCCAT
Apoptosis cellular tumor antigen p53 (p53) BT058777 (F):CATCATCACCCTGGAGACA; (R):CACACACGCACCTCAAAG
Transcription Factors
Krüppel-like factor 4 (klf4) NM_001142713 (F):GCATACGGCAGCAGCAACTT; (R):GCTCGGCTACCAGACTGTGT
krüppel-like factor 11 (klf11) BT043977 (F):CGCTCTCCTCCTTGTGTATGA; (R):TGTGGATGGCAGTGGTAGA
krüppel-like factor 2 (klf2) BT059519 (F):GGTTGTGGCTGGAAGTTC; (R):CAGTGTGCTTACGGAAATGG
Inflammation arachidonate 5-lipoxygenase (lox5) NM_001139832 (F):ATCCACCAGACAGTCACACACCTTC; (R):GCCACTCCAAACACCTCCGAGAC
Table 1. List of selected genes and forward and reverse primers for real-time qPCR.
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Expression of mapk and p38b genes did not show significant changes in the field samples, but erk3 and jnk1 
were significantly up- and down-regulated, respectively, at clinical stages of infection in the in vivo challenge. 
Krüppel-like factors klf2 and klf4 were consistently down-regulated in clinical AGD and AGD lesions in the in 
vivo challenge and field samples, and showed a slight up-regulation post-treatment. No changes were detected 
for klf11.
In the in vivo challenge samples, significant up-regulation at 14 and/or 21 dpi was detected for pcna, egfr, 
p53, phb and ppia, while nrf2 was down-regulated, and lox5 showed up- and down-regulation at 2 and 21 dpi, 
respectively. Fewer changes were detected in the field samples. pcna and phb were up-regulated in lesion areas at 
Figure 4. Phylogenetic tree of protein sequences for Muc5, Muc2 and Muc18, including the Atlantic salmon 
sequences used in the present study. GenBank accession numbers are provided for each sequence.
Figure 5. PCA analysis for the in vivo challenge samples representing the distribution of infected samples at 2, 
7, 14 and 21 dpi. Analysis was based on fold-changes of all genes for each individual sample (smaller symbols) 
relative to the negative control at each time point. The ellipses indicate the group dispersion/variability from the 
centroid (larger symbols) calculated using all individual fold-changes values/group.
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GS 1, and p53 was up-regulated post-treatment. Treatment resulted in a shift on nrf2 and lox5 expression, with 
up-regulation of both genes after treatment. hsp70 showed no changes during the in vivo challenge and in the field 
samples hsp70 only appeared significantly up-regulated after treatment.
Discussion
In the current study, we investigated the expression of a panel of selected genes to define their involvement in 
Atlantic salmon gills during AGD. Being the hallmarks of AGD increased production of mucus and hyperplasia 
of the lamellar epithelium, we specifically targeted genes that could be directly related to these pathways. The 
study was performed using samples from an experimental infection with controlled parameters, but also from a 
natural outbreak in a farm, including a sampling point post-freshwater treatment to eliminate the amoebae. In the 
field of fish diseases, most gene expression studies are performed using experimental samples, but field samples 
are also required in order to validate the results obtained under laboratory conditions. The results from both trials 
were very consistent and underlined the importance of mucins and Th2 cytokines in AGD. Indeed, the predictive 
model constructed, based on the expression values of these genes from the experimental infection, was able to 
accurately predict the disease severity of the field samples, exposing the experimental infection model as a reliable 
tool to study this disease under controlled conditions. To our knowledge, this is the first report on Atlantic salmon 
gill mucins regulation upon gill disease, and pose an important starting point for future characterizations of the 
poorly known fish mucins.
PCA of the in vivo challenge and field samples showed consistent clustering of the different sampling groups, 
and an increasing separation of groups upon disease severity. Thus, the expression profile of the selected genes 
provided a good measure on the advancement of the disease. In fact, out of the 21 genes in the array, 17 and 14 
genes were significantly regulated in the in vivo and field experiments, respectively. In addition, PCA results of 
field samples highlighted the multifocal distribution of the gill lesions, with the highest variability in lesion areas. 
Lesion-specific regulation was previously described in genes involved in immunity26,27 and antigen processing 
and presentation30. Interestingly, gills were able to partially revert the changes in the expression of the selected 
genes as rapidly as four days after freshwater treatment and, as expected, the reversion to control levels was almost 
Figure 6. (A) PCA analysis for the field samples representing the distribution of lesion samples of GS 1, GS 
2 and treated groups. Analysis was based on fold-changes of all genes for each individual sample (smaller 
symbols) relative to GS 0. The ellipses indicate the group dispersion/variability from the centroid (larger 
symbols) calculated using all individual fold-changes values. (B) PCA analysis for the field samples representing 
the distribution of lesion and non-lesion samples of GS 1, GS 2 and treated groups. Analysis is based on fold-
changes of all genes for each individual sample relative to GS 0. For clarity, individual values were omitted from 
the plot and only the group centroids were plotted.
Group GS 0 GS 1 Lesion GS 1 Non-lesion GS 2 Lesion
GS 2 Non-
lesion Treated Lesion
Treated Non-
lesion
Predicted GS 0.14 ± 0.078 1.03 ± 0.419 −0.01 ± 0.089 2.09 ± 0.519 0.03 ± 0.102 −0.19 ± 0.029 0.05 ± 0.061
Table 2. Field experiment gill score values predicted using partial least squares regression. The model was 
constructed using the expression values of the genes that contributed most to the variability observed in 
components 1 and 2 of the PCA analyses shown in Figs 5 and 6 (muc5, muc18, muc2, il4/13a, il4/13b2 and 
tnfα3) as X variables, and gill score (GS) as Y variable. The in vivo challenge dataset served as the training set. 
Values show the mean (±SEM) predicted GS of the different field experiment sample groups.
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complete in non-lesion areas. Even though the experimental design and analysis differed between trials, gene 
expression results from challenge and field samples showed similar and comparable trends, and in both scenarios 
changes in mucins and cytokines accounted for most of the variability observed between groups, highlighting 
their key role in AGD.
Two different mucin sequences, muc5 (secreted and gel-forming) and muc18 (membrane-bound), were 
consistently detected in gills of Atlantic salmon. muc5 was substantially up-regulated in fish displaying clinical 
AGD, and in AGD lesions relative to non-lesion areas; whereas muc18 was significantly down-regulated at 21 
dpi. Secreted mucins are responsible for the rheological properties of mucus, and muc5 is most likely the main 
component of the characteristic mucus patches comprising AGD lesions. A sequence characterised as muc2 was 
also detected in gills, but the expression was very low and variable among individuals. Muc2 is the major secretory 
mucin in intestine of mammals and fish16,18. Muc2 has also been detected in mammalian respiratory epithelium, 
but, similar to the results in gills, its expression in lung is in some cases weak or undetectable38. These results 
indicate a key role of Muc5-type mucins in respiratory organs of fish, as is the case in mammals, and show the 
potential of muc5 as biomarker for AGD. Indeed, MUC5AC and MUC5B are the principal components of airway 
mucus in humans39, and overexpression of one or both types is a hallmark of different airway diseases15,40. In 
mammals, birds and reptiles, type 5 mucins are divided into Muc5AC and Muc5B, but this classification is not 
so clear in fish and amphibians17,41. This complexity and unclear classification was evidenced in the phylogenetic 
analysis, where the Atlantic salmon muc5 sequence grouped together with both mucins described as Muc5AC 
and Muc5B. Sveen et al.21 reported seven genes of secreted mucins in Atlantic salmon (i.e. muc5ac.1, muc5ac.2, 
muc5ac.3, muc5ac.4, muc5b, muc2.1, muc2.2), of which, muc5 genes were detected in gills, skin and pyloric caeca 
(genes labelled as muc5ac.2 and muc5ac.4 being the highest expressed in gills), whereas muc2 genes showed 
highest expression in intestine and pyloric caeca. In their study, Sveen et al.21 showed upregulation of muc5ac.2/4 
and muc2.1/2 in gills after handling stress, but the FC for muc5ac.2/4 (i.e. FC = 0.8) was significantly lower than 
the one reported here for muc5 upon parasitic infection. In zebrafish, six partial muc5-type sequences have been 
identified (labelled muc5.1 to muc5.6), of which muc5.1 and muc5.2 are detected in gills, but only muc5.1 in 
lamellae16,17. Mucin sequences described as muc5B in common carp19 and muc5AC in channel catfish (Ictalurus 
punctatus)42 have also been detected in gills. Mucus properties and composition vary among fish species and can 
change depending on disease and environmental factors43,44. In a previous study, the increase in goblet cells num-
bers in AGD lesions was found to be predominantly due to an increase in the number of cells containing neutral 
mucins, although a slight increase in cells containing carboxylated mucins was also observed45. In another study, 
Figure 7. Relative expression of genes showing statistically significant changes (+p < 0.1, *p < 0.05, **p < 0.01) 
in the in vivo challenge experiment. Mucins and cytokines are represented in (A), and the other differentially 
expressed genes are shown in (B). Fold changes (FC) were calculated as the relative expression in the infected 
(positive) versus the non-infected (negative) samples. Genes showing FC > 1 were up-regulated in infected 
samples, whereas genes with FC < 1 were down-regulated in infected samples.
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Roberts & Powell44 detected decreased viscosity and increased glucose and protein concentration in skin mucus 
of AGD affected fish.
Gill diseases can be caused by numerous agents, but morphologic patterns of tissue reaction are limited. 
Comparative pathology with other respiratory disorders can provide valuable insights into pathogenic mecha-
nisms and potential therapeutic targets. Many chronic inflammatory airway diseases in mammals involve mucus 
hypersecretion, and different stimuli and signaling pathways have been investigated in relation to mucin over-
production and goblet cell hyperplasia and metaplasia. The mechanisms underlying mucus hypersecretion in 
fish have been less explored, but interspecies extrapolation may be possible based on conserved gene functions. 
Th2 cytokines (mostly IL13) in mammals are known to stimulate goblet cell hyperplasia and overexpression of 
Muc5AC and/or Muc5B32,33,46, and the distinct pattern of muc5 and il4/13a and il4/13b2 expression detected in 
AGD may indicate a similar mechanism in fish. Benedicenti et al.23 reported up-regulation of the fish homo-
logues il4/13a and il4/13b2 and down-regulation of Th1, Th17 and Treg markers in late stage AGD. The present 
study showed up-regulation of il4/13a and il4/13b2 in infected fish as early as 2 dpi and they were particularly 
over-expressed in lesion areas. This demonstrates the rapid and lesion-specific response of gills to the parasite 
and the importance of il4/13a and il4/13b2 on AGD pathogenesis. Based on the results obtained for the different 
sampling points in both trials, up-regulation of il4/13a may appear slightly more consistent and specific to the 
infection than il4/13b2.
EGFR promotes cell proliferation, differentiation and migration, but it is also a key target leading to goblet 
cell hyperplasia/metaplasia34,47 and MUC5AC expression35,48. EGFR has been related to IL13-induced epithelial 
proliferation49 and mucin production50 in mammals. TNFα can also stimulate EGFR expression, but no changes 
in tnfα1 or tnfα2 were detected in previous AGD investigations23,24,51 and tnfα3 in the present and a previous23 
study was significantly down-regulated in clinical AGD. TNFα is one of the main acute pro-inflammatory 
cytokines, and the decreased expression of tnfα3 could be interpreted as an impaired immune response to the 
disease. However, TNFα and TGFβ can also induce growth arrest and/or apoptosis52,53, and therefore their 
down-regulation is probably more related to sustaining the prominent cell proliferation occurring in AGD. LOX5 
has a central role in the biosynthesis of leukotrienes, inflammatory mediators with important roles in allergy 
and innate and adaptive immunity54–56. The expression profile of lox5 observed during N. perurans infection 
showed an initial increase at 2 dpi, suggesting an early triggering of the leukotriene pathway. However, at 21 dpi, 
the expression of lox5 was significantly down-regulated suggesting an impaired host response or, more likely, a 
Figure 8. Relative expression of genes showing statistically significant changes (+p < 0.1, *p < 0.05, **p < 0.01) 
in the field samples. Mucin and cytokines are represented in (A), and the other differentially expressed genes are 
shown in (B). Fold changes (FC) were calculated as the relative expression in lesion (L) versus non-lesion (NL) 
areas for GS 1 and GS 2, and in lesion areas post-treatment (TX-L) versus lesion areas at GS 2. Genes showing 
FC > 1 were up-regulated in lesion areas or post-treatment, whereas genes with FC < 1 were down-regulated in 
lesion areas or post-treatment.
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specific regulation of this pathway at later time points. In fact, in mammals IL4/IL13 can inhibit LOX5 and con-
comitantly up-regulate LOX15 expression in dendritic cells57.
Muc18, also named melanoma cell adhesion molecule, belongs to the immunoglobulin superfamily. muc18 
was the most abundant mucin detected in gills of gilthead sea bream18 and, in accordance, its relative expression 
in the present study was much higher than that of muc5 (Supplementary Tables S2 and S3). Muc18 is involved in 
cell-cell interactions and cell migration, and altered expression can affect cell motility and invasiveness58; reason 
why Muc18 has been studied in tumorigenesis and reported to be up- or down-regulated depending on the type 
of cancer59–61. Pro-inflammatory roles of Muc18 have also been described62, and its expression is increased in 
airway inflammation63,64. The role of this abundant membrane-bound mucin in gills and the stability of the gly-
cocalyx remains to be investigated.
Krüppel-like factors (KLFs) and mitogen activated protein kinases (MAPKs) are involved in pathways that 
regulate cell proliferation, differentiation, stress response and apoptosis36,37. KLFs are downstream signals of 
MAPKs, and their expression was investigated to assess potential mechanisms involved in AGD epithelial hyper-
plasia. All main members of the MAPK family have been identified in fish65, but limited data exist on mapk 
expression during infectious diseases in fish. Three important representatives of the MAPK family (erk3, jnk1 
and p38b) were included in this study. MAPKs pathways are well conserved across vertebrates and the MAPK 
family is divided into four main cascades: the extracellular signal-regulated kinase 1/2 (ERK1/2), the c-Jun 
N-terminal kinase (JNK), the p38, and the ERK5 cascade. Largely, JNK and p38 signaling pathways are acti-
vated by pro-inflammatory cytokines, including IL1ß, TNFα and IL6, or in response to cellular stress, leading 
to inflammation, cell cycle arrest and/or apoptosis; while ERK1/2 is mostly activated by mitogenic factors and 
growth factors to promote cell proliferation and prevent apoptosis36,66,67. ERK3 is considered an atypical MAPK 
with unclear functions to date, but there are reports of increased ERK3 expression associated with cell prolifer-
ation68. erk3 and jnk1 changes detected in the present study were small but consistent with a cell proliferation 
process. It is important to note that activation of MAPKs is induced by phosphorylation. Therefore, gene expres-
sion analyses, while providing a hint on the pathways involved, might not be enough to completely define the 
contribution of these proteins in AGD progression and resolution.
KLFs are zinc finger-containing transcription factors and alterations in their expression and function have 
been associated with several human diseases37. Information on fish KLFs is very scarce, but interest exists on the 
conservation and function of the homologues proteins in lower vertebrates69. In mammals, KLF2 and KLF4 are 
highly expressed in lung and gastrointestinal tract, respectively70. In the present study, the relative expression of 
klf2 was considerably higher than that of klf4 (Supplementary Tables S2 and S3), which indicates a potential con-
servation and association of KLF2 with respiratory organs. KLFs can function as cell cycle activators or repressors 
in a cell type- and promoter-dependent manner, but KLFs are emerging as potential tumour suppressor genes 
and down-regulation of both KLF2 and KLF4 has been associated with several cancer types71–74. The significant 
down-regulation of klf2 and klf4 detected in both in vivo challenge and field samples, indicates a function in cell 
cycle arrest of these genes in AGD. KLF2 is also involved in immunity and suppression of KLF2 in dendritic cells 
has been reported to amplify Th2 responses75. In addition, KLF2 has been described to inhibit pro-inflammatory 
activation of monocytes in mammals76 and in fish77. Lu et al.77 showed that Klf2 knockdown in Plecoglossus altive-
lis monocytes/macrophages resulted in the enhancement of cytokine production (Il1β, Tnfα), phagocytotic and 
bactericidal capability after Listonella anguillarum exposure. On the other hand, KLF4 is associated with goblet 
cell differentiation in the gastro-intestinal tract78, and a similar role has been reported in zebrafish79.
Down-regulation of tumour suppressor p53 (p53) has been suggested as one of the mechanisms underlying 
cell proliferation in AGD28, but this pattern was not observed in the current study. This differing result shows 
the value of multiple studies and the use of field samples, as several factors, including infection dose, sampling 
times, fish size, and previous disease status, among others, may affect gene expression results. On the other hand, 
p53 appeared up-regulated after freshwater treatment, which suggests its involvement in cell death and tissue 
remodelling post-treatment. NRF2 regulates the expression of antioxidants and its down-regulation in challenge 
and field samples is indicative of oxidative stress, which has previously been associated with AGD pathogene-
sis29,80. Moreover, NRF2 deficiency can exacerbate airway injury and inflammation in mammals81–83. Phb, Ppia 
and Hsp70 protein levels were significantly increased in AGD affected fish in a former proteomic study31. Phb 
and Ppia are related to inflammation, cell proliferation and inhibition of oxidative stress induced apoptosis. 
Consistently, phb was up-regulated in challenge and field samples. In our former proteomic study31, with an 
experimental setup comparabale to the one used for the current challenge experiment, Phb showed 1.2 and 1.6 
fold change increase after 14 and 21 dpi, respectively. These values are consistent with the present results of the 
challenge experiment where phb was also significantly up-regulated at 14 and 21 dpi with FC values of 1.59 and 
1.50, respectively. On the other hand, the proteomic study showed significant up-regulation of Ppia after 2, 7 and 
14 dpi with FC values of 1.3, 1.3 and 1.5, respectively, whereas, in the current study up-regulation of ppia was 
mostly not significant. Protein abundance of Hsp70 did not correlate with gene expression, and hsp70 was only 
up-regulated post-treatment.
In conclusion, AGD progression was characterised by the up-regulation of the Th2 IL4/13 cytokines, and 
genes related to mucin secretion and cell proliferation, while a number of Th1 cytokines and pro-apoptotic 
genes were down-regulated. Currently used treatments against AGD aim to remove excessive gill mucus 
and eliminate pathogenic amoebae. Gills hold an extraordinary plasticity and repair capacity, and the results 
obtained post-treatment in the present study show that freshwater bath is not only effective against the para-
site, but also supports the partial restoration of the host immune, mucosal, structural and anti-oxidant status. 
An increased rate of apoptosis and supressed rate of mitosis are most likely involved in the gill remodelling 
occurring post-treatment. The current results also show the activation of Th2 cytokines as early as 2 dpi, and 
suggest an association of il4/13a and il4/13b2 expression with muc5 expression and secretion. In mammals, goblet 
cell hyperplasia and increased mucus secretion mediated by Th2 immune responses (IL13 and IL4) are known 
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mechanisms for certain parasitoses such as infections with helminth parasites Nippostrongylus brasiliensis and 
Trichinella spiralis84,85. In AGD pathogenesis, the type 2 response characterised by higher expression of il4/13a, 
il4/13b223 and arg2b86 has been proposed to be related with activation of alternative (M2) macrophages. M2 mac-
rophages already showed to be crucial, particularly due to their important tissue repair function, against helmint 
parasites infections87. Thus, the presence and activation of M2 macrophages during AGD should be further stud-
ied. Mucus hypersecretion and cellular hyperplasia go hand in hand during AGD, and both changes are restricted 
to lesion areas with the presence of amoebae. Interactions and common mechanisms are therefore likely; e.g. Th2 
cytokines have been associated with epithelial proliferation and anti-apoptotic mechanisms88–90, and aberrant 
mucin expression occurs in certain types of cancer38.
This is the first study exploring expression of gill mucins in Atlantic salmon during an infectious process. The 
results show the importance of muc5 in AGD pathology and severity, and prove the effectiveness of freshwater 
treatment to reestablish gill homeostasis under field conditions. Gill diseases are currently one of the main health 
challenges for the industry, but significant knowledge gaps still exist on gill mucosal immunity and respiratory 
pathogenesis. Further research on muc5 sequences and their differential expression in different gill conditions of 
Atlantic salmon and other fish species would contribute to improve our understanding of gill health.
Materials and Methods
All methods described were carried out in accordance with relevant guidelines and regulations. All experimental 
protocols were approved by The Health Products Regulatory Authority (HPRA) in Ireland under project authori-
sation number AE19114/P001, and following the Animals Scientific Procedures Act 1986 (Directive 2010/63/EU 
transposed into Irish law by S.I. No 543 of 2012).
In vivo challenge. Samples for this study were obtained from a previous challenge described in Marcos-López 
et al.31. Figure 1 summarizes the details of the in vivo challenge.
N. perurans isolation and experimental bath challenge. Gill mucus containing N. perurans was collected from 
naturally infected Atlantic salmon (displaying clinical AGD) from a commercial farm in the west of Ireland. 
Infected mucus was transferred into filtered sterile sea water, and the suspended solution plated into marine malt 
yeast agar plates. The amoeba culture (Fig. 2A) was maintained at 18 °C and species identification was confirmed 
by real-time polymerase chain reaction (PCR), as described by Downes et al.91. The experimental challenge was 
carried out at the Daithi O’Murchu Marine Research Station (Bantry, Co. Cork, Ireland). Naïve Atlantic salmon 
smolts (~85 g; n = 300) were distributed into four circular 1,000 L tanks (n = 75) and left to acclimatise for 10 
days. Two tanks were challenged with 1,800 amoebae/L (infected tanks), whereas the other remaining two tanks 
were kept as negative controls (non-infected tanks). Prior to the inoculation with N. perurans, the water level of 
all tanks, including the control ones, was lowered to 300 L. Following inoculation, all tanks were maintained for 
4 h at 300 L and subsequently refilled to 1,000 L. Water temperature ranged from 10.5 °C to 11.5 °C and salinity 
was 35 practical salinity units (PSU). Fish were fed a commercial salmon diet at 1% body weight per day.
Collection of samples. Sampling points were set at 2, 7, 14 and 21 days post-infection (dpi). At each sampling 
point, 10 fish per tank were anaesthetised with 100 mg L−1 of tricaine methanesulfonate (Tricaine, Pharmaq), 
and gills scored as per the standard protocol used in Atlantic salmon aquaculture. Gill scoring, adapted from 
Taylor et al.92, is a visual scoring system entailing a macroscopic examination of all gill arches (Fig. 2B) of each 
individual fish for the presence and extent of AGD lesions. The severity of the macroscopic lesions ranges from 0 
(non-affected) to 5 (severely affected). Out of the 10 fish examined per tank at each time point, 3 fish were euth-
anized with an overdose of anaesthetic (400 mg L−1 of tricaine methanesulfonate) and gill samples excised and 
placed into RNAlaterTM (Ambion) for gene expression analysis. Gill samples were taken from the 2nd right gill 
arch. In AGD positive fish showing no AGD lesions in the 2nd right gill arch, samples were taken from adjacent 
arches to ensure inclusion of lesion areas. Samples were stored at −80 °C until use. The remaining seven fish per 
tank were allowed to recover in clean oxygenated seawater and returned to the trial tanks. In addition, histology 
samples and gill swabs for N. perurans PCR91 were taken to confirm AGD and presence of N. perurans. For histo-
logical analyses, samples were fixed in 10% neutral buffered formalin, routinely processed, embedded in paraffin 
wax blocks, sectioned (3–5 μm), and stained with haematoxylin and eosin (H&E).
Field sampling. Samples for this study were obtained from a previous sampling described in Marcos-López 
et al.93. A summary of the details for the field sampling can be found in Fig. 1.
Fish and environmental conditions. Atlantic salmon S1 smolts (average initial weight 67 g, initial stocking den-
sity 0.55 kg m−3) in a commercial farm in north west Ireland were monitored from sea transfer (29th March 2016) 
until development of first gross signs of AGD (80 days post-transfer (dpt)) and subsequent freshwater bath treat-
ment (<3 practical salinity units (PSU) for 3 h) at 108 dpt. Gill scoring was conducted on a weekly basis, and sam-
pling points were set at gill score (GS) 0 (fish showing no gross AGD lesions), GS 1 (early AGD), GS 2 (advanced 
AGD), and 4 days after freshwater treatment. Accordingly, sampling points took place at 21 dpt (GS 0), 85 dpt (GS 
1), 92 dpt (GS 2), and 112 dpt (4 days post freshwater treatment). Average weights for the four sequential sam-
pling points were 85.2 g, 282.0 g, 312.1 g and 375.3 g, and water temperature was 9 °C, 14.9 °C, 15.0 °C and 15.2 °C, 
respectively. Salinity was 32 to 33 PSU through the entire monitoring period, and fish were fed a commercial 
salmon diet at 2% body weight per day.
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Collection of samples. At each sampling point, 30 randomly caught fish from a single pen (same pen sampled 
in all time points) were anaesthetised with 100 mg L−1 of tricaine methanesulfonate and gills scored as described 
for the in vivo challenge. Five fish showing equal GS were further euthanized with an overdose of anaesthetic 
(400 mg L−1 of tricaine methanesulfonate), and gill samples excised and stored as described for the in vivo chal-
lenge. Separate samples comprising gill areas with and without AGD lesions were taken for GS 1 and GS 2 and 
post-treatment. As defined for the in vivo challenge, gill swabs for PCR and histology samples were taken to 
confirm infection and disease.
Gene sequence analysis and primer design. The panel of genes selected for this study included mucins 
(muc18, muc5, muc2), mitogen-activated protein kinases (mapk), cytokines (tnfα3, tgfβ1b, il4/13a, il4/13b2), an 
oxidative stress marker (nuclear factor erythroid 2-related factor 2 (nrf2)), proteins previously detected to be dif-
ferentially expressed in AGD in a proteomic study31 (prohibitin (phb), peptidylprolyl isomerase (ppia), heat shock 
70 kDa protein (hsp70)), markers of cell proliferation (proliferating cell nuclear antigen (pcna), epidermal growth 
factor receptor (egfr)), a marker of apoptosis (cellular tumour antigen p53 (p53)), Krüppel-like factors (klf4, klf11, 
klf2), and a marker of inflammation (arachidonate 5-lipoxygenase (lox5)).
The sequence for mucin 5 (muc5) was obtained from an isotig sequence (isotig 05987) reported in Atlantic 
salmon skin22. Other mucin sequences were identified by BLAST queries (E-value < 4e−75) using mucin sequences 
reported in other fish species (Sparus aurata18; Cyprinus carpio19; Danio rerio, http://www.medkem.gu.se/mucin-
biology/databases/db/Mucin-zebrafish-2015.htm). Sequences for the other selected genes were obtained from 
published data in Atlantic salmon, term-searches in GenBank for automatically annotated genes, and BLAST 
queries using sequences described for other fish species. Primers were designed to obtain amplicons of 50–150 bp 
in length using Beacon designer 7.60. See Table 1 for a list of selected genes, accession numbers and primer 
sequences.
Sequence alignments and phylogenetic analysis of mucin sequences analysed in Atlantic salmon gills in this 
study (muc5, muc18, muc2) and 17 other mucin sequences from 10 different species were carried out in MEGA 
version 694. A phylogenetic tree was constructed using the Neighbor Joining method with the Poisson model, and 
reliability of the tree was assessed by bootstrapping, using 1,000 bootstrap replications.
Gene expression analysis. Total RNA from gills was extracted with a MagMAX-96 for microarray kit 
(Life Technologies) after tissue homogenization in TRI reagent following manufacturers’ instructions. RNA 
quantity and purity was determined by Nanodrop (Thermo Scientific) with absorbance ratios at 260 nm/280 nm 
above 1.9. Reverse transcription (RT) of 500 ng of total RNA was performed with random decamers, using the 
High-Capacity cDNA Archive Kit (Applied Biosystems) following manufacturers’ instructions. RT reactions were 
incubated for 10 min at 25 °C and 2 h at 37 °C. Negative control reactions were run without reverse transcriptase. 
During the design of the array, at least two sets of primers were designed for all the targeted molecules and path-
ways. All primer sequences were blasted against the available databases to rule out possible amplification of sim-
ilar undesired products. Specificity and performance of each pair of primers was assessed by analysis of melting 
curves and linearity of serial dilutions of RT reactions. PCR product presence and sizes were checked in a 1% aga-
rose gel. Only primers for genes with clear expression in gill tissue (Ct values of undiluted samples <30 and pres-
ence of a clear band in the gel), and all with similar efficiencies and between 90 and 98% were used in the study. 
Real-time quantitative PCR was carried out with a Mastercycler Ep Realplex real-time PCR system (Eppendorf) 
using a 96-well PCR array layout designed for the simultaneously profiling of a panel of 21 genes. Each PCR-well 
contained 12.5 µl SYBR Green Master Mix (Bio-Rad), 5 µl of specific primers at a final concentration of 0.9 µM, 
and 7.5 µl diluted RT reaction. PCR amplification included an initial denaturation step at 95 °C for 3 min, followed 
by 40 cycles of denaturation for 15 s at 95 °C and annealing/extension for 60 s at 60 °C. The specificity of reactions 
was verified by analysis of melting curves. Controls for general PCR performance were included on each array, 
and all the pipetting operations were performed with the EpMotion 5070 Liquid Handling Robot (Eppendorf). 
The efficiencies of all PCR runs were always higher than 90% (ranging from 91 to 99%). Data acquired during 
the PCR extension phase were normalised using the delta-delta Ct method95. Four potential housekeeping genes 
(β-actin, elongation factor 1α, α-tubulin and 18S rRNA) were previously tested for stability using the GeNorm 
software. The most stable reference gene among conditions was β-actin and it was used in the normalization 
procedure. For multi-gene analysis comparisons, relative gene expression was referenced to the expression level 
of egfr of control fish (negative control at 2 dpi for the challenge samples and GS 0 for the field samples) with an 
arbitrarily assigned value of 1.
Statistical analysis. Principal component analyses (PCA) were performed using fold-changes of all indi-
vidual samples relative to the negative control at each time point for the in vivo challenge or relative to GS 0 for 
the field experiment. The default prcomp function of the R statistical software (v3.0.2) was used to calculate the 
principal components and visualizations were constructed using the factoextra (v1.0.4) and gplots (v3.0.1) R pack-
ages. Ellipses in the PCA graphs are confidence ellipses with a confidence level of 0.95 and the centroids represent 
the center of the mass of the points per group. Partial least squares regression (PLSR) was performed using the 
pls (v2.6.0) R package. The model was constructed using the expression values of muc5, muc2, muc18, il4/13a, 
il4/13b2 and tnfα3 (selected due to their high contribution in the PCA analyses) as X variables, and gill scores 
(GS) as the Y variable. The data from the controlled in vivo challenge experiment was used to train the model. The 
best performing model in the training dataset cross-validation (LOO or leave-one-out cross-validation) was the 
one using 3 components (root mean square error, RMSE = 0.59). This model was used to predict the GS of the 
field experiment (RMSE = 0.51). Gene expression data were represented as fold change (FC) ± SEM. FC for the 
challenge samples were calculated using the relative expression of the AGD positive samples versus the negative 
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control at each time point. FC for the field samples were calculated using relative expression in lesion versus 
non-lesion areas for GS 1 and GS 2 to assess specificity/distribution of changes during clinical AGD, and using 
relative expression in lesion areas post-treatment versus lesion areas at GS 2 to assess treatment effects. Statistical 
analyses and graphs were performed using GraphPad PRISM v7.0. Differences were evaluated using the Student’s 
t-test, after checking that the data were normally distributed, and the significance level was 95% (p < 0.05) unless 
otherwise stated.
Data Availability Statement
All data supporting this study is included in the results section of the manuscript, the supplementary material or 
openly available in public databases.
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